ESBC
LLY icon

E.S. Barr & Co’s Eli Lilly LLY Stock Holding History

E.S. Barr & Co’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.98M Sell
3,236
-5
-0.2% -$5.07K 0.17% 42
2025
Q4 		$3.48M Sell
3,241
-70
-2% -$66.9K 0.18% 39
2025
Q3 		$2.53M Hold
3,311
– – 0.14% 44
2025
Q2 		$2.58M Buy
3,311
+70
+2% +$54.4K 0.15% 42
2025
Q1 		$2.68M Sell
3,241
-5
-0.2% -$4.16K 0.16% 42
2024
Q4 		$2.51M Sell
3,246
-29
-0.9% -$24K 0.15% 44
2024
Q3 		$2.9M Buy
3,275
+14
+0.4% +$12.6K 0.18% 42
2024
Q2 		$2.95M Hold
3,261
– – 0.19% 40
2024
Q1 		$2.54M Hold
3,261
– – 0.17% 43
2023
Q4 		$1.9M Sell
3,261
-125
-4% -$73K 0.13% 45
2023
Q3 		$1.82M Hold
3,386
– – 0.13% 44
2023
Q2 		$1.59M Buy
3,386
+274
+9% +$115K 0.12% 48
2023
Q1 		$1.07M Hold
3,112
– – 0.09% 49
2022
Q4 		$1.14M Hold
3,112
– – 0.09% 50
2022
Q3 		$1.01M Hold
3,112
– – 0.09% 54
2022
Q2 		$1.01M Sell
3,112
-100
-3% -$30K 0.08% 55
2022
Q1 		$920K Sell
3,212
-1,000
-24% -$257K 0.06% 57
2021
Q4 		$1.16M Sell
4,212
-13
-0.3% -$3.3K 0.08% 54
2021
Q3 		$976K Buy
4,225
+13
+0.3% +$3.21K 0.07% 54
2021
Q2 		$967K Buy
4,212
+2,000
+90% +$402K 0.07% 52
2021
Q1 		$413K Hold
2,212
– – 0.03% 66
2020
Q4 		$373K Hold
2,212
– – 0.03% 65
2020
Q3 		$327K Hold
2,212
– – 0.03% 66
2020
Q2 		$363K Hold
2,212
– – 0.04% 66
2020
Q1 		$307K Hold
2,212
– – 0.04% 69
2019
Q4 		$291K Hold
2,212
– – 0.03% 70
2019
Q3 		$247K Hold
2,212
– – 0.02% 73
2019
Q2 		$245K Hold
2,212
– – 0.02% 73
2019
Q1 		$287K Buy
2,212
+50
+2% +$6.08K 0.03% 68
2018
Q4 		$250K Hold
2,162
– – 0.03% 74
2018
Q3 		$232K Buy
+2,162
New +$216K 0.02% 85

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

E.S. Barr & Co's LLY Position: Q1 2026 in Review

E.S. Barr & Co reduced its Eli Lilly (LLY) stake by 0.15% in Q1 2026, selling an estimated $5.07K and leaving 3,236 shares worth $2.98M. The position accounts for 0.17% of the portfolio, ranked #42.

E.S. Barr & Co first reported a position in LLY in Q3 2018 and has held it in 31 quarters since. The position peaked at $3.48M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • E.S. Barr & Co held 3,236 shares of Eli Lilly worth $2.98M as of Q1 2026.
  • E.S. Barr & Co sold 5 Eli Lilly shares in Q1 2026, an estimated $5.07K.
  • Eli Lilly made up 0.17% of E.S. Barr & Co's portfolio in Q1 2026, its #42 holding.
  • E.S. Barr & Co first reported a position in Eli Lilly in Q3 2018 and has held it in 31 quarters since.
  • E.S. Barr & Co's Eli Lilly position peaked at $3.48M in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on E.S. Barr & Co's 13F filing for Q1 2026, filed 13 May 2026.